The Nifty closed at 24,383.60, up 0.27% on the day and up 2.59% over five sessions. But it has gone nowhere for a year — down 3.32% over twelve months. Beneath that flat surface, Pharma is up 18.37%, Auto up 19.37% and Metal up 32.78%, while IT is down 16.89% and FMCG down 11.83%. This is not a market you invest in broadly. It is a market you invest in selectively.

Short-term participation is healthy: 72% of indices trade above their 21-day average and 76% above their 50-day average. But only 48% trade above their 200-day average, meaning half the market still has no long-term uptrend to stand on. Trend strength on the benchmark reads 10.7 on a scale where anything below 20 signals no trend at all. Volatility is unusually calm and the volatility index sits at 11.76, a level that historically reflects complacency rather than confidence.

55% deploy now — into the top-ranked sectors, in tranches  ·  45% hold in cash — for a dip toward 23,600 or a confirmed break above 24,531

This is deliberately more cautious than a typical week. When the index sits under resistance with its heaviest sector group weakening, the cost of waiting seven days is small and the cost of being fully invested into a failed breakout is not.

Range estimate derived from the benchmark’s average daily range of 0.90% extended across five sessions. It describes typical movement under current volatility, not a forecast. Confidence in this view: MEDIUM — supported by clear trend structure and sector rankings, limited by weak trend strength, a market regime that changed three times in eight days during July, and degraded data on five indices.

Every sector scored 0–100 across seven weighted inputs: trend strength, relative strength, momentum, value opportunity, timeframe alignment, risk and confirmation. One number, ranked every week. No row is left for you to interpret.

A high score is not the same as a good entry price. The best sector on this list is also the one with the least room left to run. Separating quality from opportunity is what decides whether you should hold something or buy more of it today.

Four things happened over the last twenty trading sessions. Together they explain most of what you are seeing in your portfolio.

Private Bank fell from 3rd place to 22nd in relative performance. Financial Services fell from 4th to 18th. Bank fell from 6th to 20th. All three turned negative on trend within the same week. This is not one bank having a difficult month; it is the entire financial sector losing institutional sponsorship simultaneously, which is a far more meaningful signal.

Money did not leave the market when it left banking — it moved. Pharma and Healthcare both now trade at all-time highs. Auto has gained 7.47% in a month. These three occupy three of the top four positions in our ranking, and they attracted flows steadily rather than in a single burst, which is characteristic of institutional rather than retail buying.

Twenty sessions ago IT ranked 23rd out of 24. Today it ranks 1st. It gained 6.75% in five sessions and 7.88% in a month. But it remains 23.8% below its 52-week high and is still down 16.89% over the past year. This is a bounce from a deep hole, not a restored leader — and the distinction matters for how you size the position.

Metal’s trading range has compressed to its tightest level in months while its relative rank climbed from 22nd to 11th. It sits 0.8% below a key resistance level. Compressed ranges store energy and typically resolve into a large move — but they resolve in either direction, and Metal’s trend strength is the weakest of any index we measure.

This is not a clean rotation from defensive sectors into cyclical ones, or the reverse. Auto and Media, both cyclical, lead alongside Pharma and Healthcare, both defensive. Meanwhile banking, the core cyclical sector, is collapsing, and FMCG, a classic defensive, remains broken. Money is simply crowding into whatever is already working, regardless of category.

That behaviour is typical of a range-bound market. It usually persists until the range breaks — and the sector most likely to break it, in either direction, is banking.

Six profiles, each assuming ₹1,00,000 of fresh money. Levels are drawn from current support and resistance readings — use them rather than improvising an entry.

Everything on the previous five pages is derived from the readings below. This page exists so you can check the reasoning rather than take it on trust.

Six indices show a bearish momentum divergence — price making higher highs while momentum makes lower highs. In plain terms, the price is still rising but with less force behind each move. Two of them are Pharma and Healthcare, our two highest-quality recommendations. This does not invalidate them, but it means their leadership is tiring and should be watched. The other four are Bank, Private Bank, Services and Smallcap 50.

Encouragingly, the Nifty 50 itself shows no divergence, and no exhaustion or reversal signals were detected across any of the 25 indices.

The underlying dataset is flagged degraded. Five indices have incomplete history, and their longer-term readings should not be relied upon:

Additional limitations worth knowing. Monthly-timeframe data is insufficient across every index, so all timeframe alignment in this report reflects daily and weekly readings only. Six indices carry historical outlier moves that distort their long-run percentile comparisons. Most importantly, this analysis is built entirely from price and indicator data — it contains no earnings, no valuations, no macroeconomic input, no fund-flow data, no global cues and no forward event calendar. Any of those can override every signal presented here.